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The current study shows that a clonal derivative of the Jurkat cell line up-rcgulatcs 
both the avidity and density of the a6431 receptor in response to phorbol 12- 
niyristate 13-acetate (PMA). This derivative attaches to tibronectin and, to a lesser 
degree, laminin constitutively. Adhesion and spreading are dramatically up-regu- 
lated following treatment with PMA. The response on fibronectin peaks within 4 
hours, is  insensitive to cyclohexaminde, can be blocked by monoclonal antibod- 
ies (Mabs) to the PI and a5 subunits of the PI family of integrins, and is not 
associated with increased expression of the a5 or PI  epitopes at the cell surface. 
In contrast, the response on laminin is biphasic. The early phase parallels the 
rcsponsc on fibronectin. The second phase peaks after 48-72 hours of treatment 
with PMA, is  sensitive to cycloheximide, can be blocked by Mabs to the f3l and 
a6 subunits, and is associated with increased expression of the a6 epitope. Both 
the density independent and dependent rcsponses to PMA in Jurkat cells are 
blocked by the protein kinase inhibitor staurosporine. The HSB-2, CEM, Molt-4, 
and HPB-ALL T-lymphoblastic cell lines also up-regulate attachment to fibroncr- 
tin and laminin following treatment with PMA. All four lines constitutively attach 
to fibronectin and show rapid up-regulation of attachment following treatment 
with PMA. Nonc of the lines attach to laminin prior to PMA treatment; however, 
specific adhesion developed after 4-1 20 hours of treatment. The most mature 
lines (Jurkat and HPB-ALL) up-regulated adhesion on laminin more rapidly than 
the less phenotypically mature lines (CEM, Molt-4, and HSB-2). In summary, 
clonal derivatives of the Jurkat cell line up-regulated attachment to laminin 
through protein kinase dcpcndcnt increases in a643 1 receptor avidity and density. 
In addition, the expression of functional receptors for laminin is linked to develop- 
mental maturity in a series of T-lymphoblastic cell lines. D 199.3 wiky-~isi.  Inr .  
The accumulation of normal and malignant lym- 
phoid cells in tissues in a multistep process. Adhesive 
interactions involving components of the extracellular 
matrix may contribute t o  several steps. In the quail, 
T-cell progenitors moving into the embryonic thymus 
express functional fibronectin receptors, follow a mi- 
gratory route containing substantial amounts of fi- 
bronectin, and accumulate in laminin-rich areas of the 
thymic rudiment (Savagner et al., 1986; 1988). In the 
human, cross-linking of the T-cell receptor augments 
binding to both fibronectin and laminin (Shimizu et al., 
199Ocj. Furthermore, the interaction of lymphocytic in- 
tegrins with fibronectin and laminin enhances prolifer- 
ation in response to T-cell receptor cross-linking 
(Shimizu et al., 1990a). Thus the interaction of T cells 
with components of the extracellular matrix may foster 
the migration, retention, and proliferation of lymphoid 
cells in tissues. 
Previous studies revealed marked differences in the 
expression of laminin and fibronectin binding activities 
on human T cells. Normal human thymocytes (Card- 
arelli and Pierschbacher, 1986, 1987) and a variety of 
T-lymphoblastic cell lines (Cardarelli et al., 1988; 
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Wilkins et al., 1991) showed constitutive or phorbol 
ester-induced binding to fibronectin but not to laminin. 
In keeping with these observations, p l  integrins with 
fibronectin binding activity (al-S/Pl) are commonly 
expressed on malignant lymphoid lines, whereas the 
major laminin binding receptor a6/pl has not been re- 
ported (Wayner et al., 1988; Hemler et al., 1987; 
Takada et al., 1987; Wayner et al., 1989). In contrast, 
circulating normal lymphocytes constitutively express 
both fibronectin (a3-a5@1) and laminin (a6ipl) recep- 
tors (Sanchez-Madrid et al., 1986; Shimizu et al., 
1990bj. The densities of the a5 and a6/Pl receptors 
increase further during conversion of naive into mem- 
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ory cells (Shimizu et al., 1990~).  These independent 
observations suggest that expression of the a6@l re- 
ceptor and laminin binding activity are developmen- 
tally regulated in both normal and malignant T lym- 
phocytes. 
The current study uses a clonal variant of the Jurkat  
cell line to examine the function and regulation of 
(u51fi1 and a61pl. In addition, evidence is presented sup- 
porting a link between developmental stage and ex- 
pression of functional receptors for fibronectin and 
laminin in T-lymphoblastic cell lines. 
MATERIALS AND METHODS 
Cells 
The Jurkat  variant used for most of the studies (Jll) 
was isolated via limited dilution cloning from a strain 
of Jurkat  cells described previously (Stoolman and 
Ebling, 1989). The parent line and all derivatives ex- 
press markers consistent with late thymic differentia- 
tion including CD3, CD4 (weak), and CD2. The Jl l  
variant expresses the peripheral lymph node homing 
receptor L-selectin (Leu 8, TQ1, LAM-1, DREG, and 
LECAM-1) a t  a higher level than the parent line and 
resting peripheral blood lymphocytes. 
The phenotypes of the HSB-2, CEM, Molt-4, and 
HPB-ALL T-lymphoblastic cell lines have been exten- 
sively reported in the literature (Delia et al., 1982; Car- 
rel et al., 1987; Stoolman and Ebling, 1989). In brief, 
the HSB-2 line expresses pan-T antigens exclusively, 
thus resembles normal thymic progenitors. The CEM 
and Molt-4 lines express CD1, CD4, and CD8, mimick- 
ing the features of stage I1 (common) thymocytes. HBP- 
ALL, like Jurkat, expresses complete T-cell receptor 
complexes (CD3 and WT31 epitopes) in addition t o  var- 
ious pan-T antigens. This is consistent with features of 
stage 11-111 (mature) thymocytes. However, unlike Jur-  
kat, HPB-ALL does not express the peripheral lymph 
node homing receptor. This molecule is normally ex- 
pressed just prior to release of stage I11 thymocytes into 
the circulation and is present on 50-80% of circulating 
T and B lymphocytes. 
Chemicals 
Purified fibronectin and laminin were purchased 
from Collaborative Research (Boston, MA). Bovine se- 
rum albumin, fraction V (BSA), was obtained from 
Sigma Chemical Co. (St. Louis, MO). RPMI 1640, glu- 
tamine, and antibiotics for tissue culture were products 
of Gibco (Grand Island, NY). The monoclonal antibod- 
ies (Mabs) to the p l  integrins were generous gifts of Dr. 
Caroline Damsky (AIIB2, BlE5, and J lB5)  (Brown et 
al., 1989; Hall et a]., 1990) and Dr. A. Sonnenberg 
(GoH3) (Sonnenberg et  al., 1988). The specificities and 
blocking activities of these antibodies have been de- 
scribed previously. An additional monoclonal antibody 
specific for the a 4  (clone HP2I1) chain was purchased 
from Amac (Portland, ME). Phorbol myristate acetate 
(PMA) was obtained from Sigma. Staurosporine was 
purchased from Kamiya Biochemical Corporation 
(Thousand Oaks, CAI. 
Cell culture and treatments 
Cell lines were maintained in bicarbonate-buffered 
RPMI 1640 medium supplemented with 10% fetal bo- 
vine serum, penicillin-G, streptomycin, and fungizone 
at 2-15 x lo5 cells/ml. Unless otherwise specified, 
treatment with PMA was initiated by adding < 1 ml of 
freshly diluted, filter sterilized PMA t o  cells at 
2-4 x lo5 cellslml in growth medium. PMA stock solu- 
tions (500 pM in 100% DMSO) were stored at -20°C 
for < 1 month prior to use. The final concentration of 
PMA was 5 nM. DMSO alone a t  0.01% had no effect on 
cell growth, differentiation, or extracellular matrix 
binding activity. Prolonged incubation with PMA re- 
sulted in growth arrest and cytotoxicity; therefore, 
dead cells were removed via sedimentation through 
ficoll prior to use in the binding assay if trypan blue 
uptake exceeded 15%. 
Adhesion assays 
Fibronectin, laminin or BSA were diluted in RPMI 
1640 medium without serum, added to 24-well tissue 
culture plates (300-500 pl containing 1-25 p,giwell) 
and incubated for 2 hours at 37°C under CO". After 
washing the plates with RPMI 1640 medium supple- 
mented with 200 pgiml BSA (subsequently referred to 
as assay buffer), cells were added to triplicate wells (1 
ml of assay buffer containing 5 x lo5 cells) and incu- 
bated a t  37°C for 4 hours. At the conclusion of the incu- 
bation, unattached cells were removed by first decant- 
ing the excess suspension and then gently adding 1 ml 
of phosphate-buffered saline (PBS) down the walls of 
each well, rocking, decanting, and drying on absorbant 
paper. The cells remaining attached were counted us- 
ing a Coulter ZX cell counter after quantitative re- 
moval with trypsin-EDTA. 
Surface marker analysis 
Indirect immunofluorescence assays for T-cell anti- 
gens were conducted in microtiter plates as follows. 
Antigen-specific mouse antihuman or rat antihuman 
(AIIBB, GoH3) monoclonal antibodies (50 pl) were com- 
bined with cells (2.5 x lo5 in 50 pl) and incubated at  
4°C for 30 minutes in PBS supplemented with 1% fetal 
bovine serum and 0.05% sodium azide (subsequently 
referred to as  FA buffer). Cells were washed twice in 
FA buffer (200 pl), resuspended, and combined with 50 
pl of FITC-labeled goat antimouse IgG (Fab'2 frag- 
ments, Cappel Laboratories, West Chester, PA) for an 
additional 30 minutes 4°C. After three washes in FA 
buffer, pellets were resuspended and combined with 
200 p1 of 2% paraformaldehyde prior to cytometric 
analysis. Both primary and secondary antibodies were 
used a t  saturating concentrations. 
In the experiment in Table 3, mean linear fluores- 
cence (MLF) for each marker was determined in 5,000 
cell samples using a Coulter Epics V Cytometer (FACS) 
as  previously described (Stoolman and Ebling, 1989). 
The signals from all cells (positives and negatives) were 
included in the determinations so that changes in both 
the percentage of cells expressing a given marker and 
antigen density were reflected in the sample mean. The 
MLFs for each marker were normalized to that for non- 
specific fluorescence, which was arbitrarily set to 1. A 
25-fold excess of pooled mouse IgG (control for T-cell 
markers) was used in the primary incubation to quanti- 
tate non-specific fluorescence. 
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Fig, 1. Time-course for PMA-induced attachment of Jurkat cells to fibronectin and laminin. Adhesion 
assays were carried out as described in Materials and Methods. The incubatinn times reflect the duration 
of co-culture with PMA prior to the start of the adhesion assay. The adhesion assay includes a 4-hour 
incubation on substrate-coated plastic. Therefore, the “time zero” point reflects changes occurring during 
the first 4 hours of incubation 
RESULTS 
Characterization of Jurkat cell adhesion to 
fibronectin and laminin 
Jurkat  cells from several sources (strains) were ex- 
amined for constitutive and PMA-induced attachment 
to fibronectin and laminin. All Jurkat strains showed 
qualitative similarities in their patterns of attachment; 
however, there were quantitative differences. The J l l  
variant, derived by limited dilution cloning of the 
strain showing the highest adhesive activity, was used 
primarily. 
Jurkat  cells attached constitutively to fibronectin 
(Fig. 1). Treatment with PMA up-regulated attachment 
- twofold and resulted in spreading of > 70% of the 
attached cells (Fig. 2) within 4 hours. Experiments us- 
ing shorter periods of incubation in the attachment as- 
say showed up-regulation within 1 hour in keeping 
with previous studies (Wilkins et al., 1991). In most 
cases, no further increases occurred with PMA treat- 
ment for as  long as 120 hours. The level of constitutive 
attachment to laminin varied in different experiments; 
however, i t  was consistently below that observed on 
fibronectin. In contrast to fibronectin, PMA-treatment 
increased adhesion and spreading on laminin at  both 
early and late time points. Adhesion peaked a t  10-20- 
fold over baseline after 48-72 hours of treatment. Poly- 
clonal antisera to fibronectin and laminin were used to 
assess the the specificity of the adhesion response on 
both substrates. Figure 3 shows that antifibronectin 
inhibited Jurkat cell attachment to fibronectin but had 
no affect on adhesion to laminin. Conversely, antilami- 
nin completely inhibited attachment to laminin but 
had no effect on attachment to fibronectin (Fig. 3). 
We next examined the effects of cyclohexamide on 
Jurkat cell attachment to fibronectin and laminin. For 
these experiments, cells were pretreated for 48 hours 
with PMA in the absence or presence of cyclohexamide 
(1 x lop7  and 5 x lOP7M). In addition, cyclohexamide 
was added to Jurkat cells, with and without PMA, a t  
the start of the adhesion assay. At these concentrations, 
cyclohexamide had no effect on basal or stimulated at; 
tachment on fibronectin (Fig. 4). In contrast, 5 x l o - ’  
cyclohexamide significantly inhibited the attachment 
of PMA-treated Jurkat cells to laminin at 48 hours. 
Higher concentrations of cyclohexamide (1 x lop6 and 
5 x lo-‘ M) were toxic to Jurkat cells after 2 4 4 8  
hours and therefore could not be used. 
Fibronectin and laminin receptors on 
Jurkat cells 
The next series of experiments evaluated the roles of 
selected p l  integrins in the attachment of the J l l  vari- 
ant to  fibronectin and laminin. Epitopes on the p l ,  a4, 
and a5 chains were strongly expressed on untreated 
cells (Fig. 5). In contast, the a6  epitopes recognized by 
Mabs GoH3 (Fig. 5) and J1B5 (not shown) were ex- 
pressed at significantly lower levels. Continuous treat- 
ment with PMA increased both the mean density and 
the percentage of cells expressing all but the a4 epitope. 
The a6 epitope showed the greatest increase over base- 
line expression, rising fourfold after 24 hours and up to 
sixfold after 48 hours (Table 1). Addition of cyclohexa- 
mide blocked these increases a t  the 24 hour time point 
(Fig. 5). Thus a t  least two known receptors for fibronec- 
tin (cu4ipl and cu5ipl) and one receptor for laminin (u6i 
p l )  were candidates for matrix adhesion receptors on 
the J l l  variant. 
The experiment depicted in Table 2 examined the 
inhibitory potency of several monoclonal antibodies to 
the @1 integrins. The pl-specific Mab AIIB2 completely 
inhibited attachment of PMA-treated Jurkat  cells to 
both fibronectin and laminin. The u5-specific Mab 
B1E5 reduced attachment to fibronectin by 76% but did 
not significantly inhibit attachment to laminin. In con- 
trast, the u6-specific Mab GoH3 blocked adhesion to 
laminin by 80% but had no affect on attachment to 
fibronectin. 
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Fig. 2. Phase-contrast photomicrographs of Jurkat cells attached to 
fibronectin or laminin. A. Untreated Jurkat cells attached to fibronec- 
tin. B. Jurkat cells treated with PMA a t  the time of assay attached to 
fibronectin. C. Untreated Jurkat cells attached to laminin. D. Jurkat 
cells pre-treated with PMA for 2 days attached to laminin. In all cases, 
the cells were added to  the substrates at  time-zero and incubated for 4 
hours. Following this, the nonattached cells were removed and the 
remaining cells were washed two times in assay buffer. They were 
then fixed in 2% glutaraldehyde and photographed under phase-con- 
trast microscopy a t  66 X magnification. 
Effect of staurosporine on PMA-induced 
expression and function of matrix receptors in 
point. However, the usual threefold increase in a6 ex- 
pression a t  the 20-hour time-point was reduced by 
Jurkat cells -85%. 
Preincubation of Jurkat cells with the broad-spec- 
trum protein kinase inhibitor staurosporine blocked 
PMA-induced increases in matrix receptor function and 
expression (Table 3). The combination of staurosporine 
and PMA increased trypan uptake by -10% relative to 
untreated cells and cells incubated with staurosporine 
alone. Therefore, the reduction in basal binding may 
reflect mild nonspecific toxicity. However, the i-educ- 
tion of PMA-dependent adhesion at both the 2- and 
20-24-hour time points was far greater than that re- 
sulting from staurosporine alone. After 2 hours of incu- 
bation, staurosporine alone reduced the number of cells 
bound to laminin from 3% to 2% and to fibronectin from 
32% to 27%. In contrast, binding of PMA-treated cells 
was reduced from 13% to 1% and from 50% to 2970, 
respectively. After 20 hours of incubation, staurospo- 
rine alone reduced the number of cells bound to laminin 
from 2% to 1% and to fibronectin from 29% to 22%. 
Attachment of PMA-treated cells was reduced from 
25% to 3% and 52% to 27%, respectively. The combina- 
tion of staurosporine and PMA had no effect on the 
levels of either the a5 or a6 epitopes a t  the 2-hour time 
Attachment of other T-lymphoblastic lines to 
fibronectin and laminin 
Four additional T-lymphoblastic lines were exam- 
ined for attachment to laminin and fibronectin. These 
were HSB-2, which resembles normal thymic progeni- 
tor cells, CEM and Molt-4, which mimic stage I1 (com- 
mon) thymocytes and HPB-ALL, which like Jurkat, 
resemble cells late in thymic development. Pooled data 
from several experiments are shown in Table 4. All of 
the cell lines adhered to fibronectin, regardless of their 
stage of development. PMA treatment resulted in an  
approximate twofold increase in attachment within 4-8 
hours, which did not increase further at later time 
points. In contrast, none of the lines showed significant 
constitutive attachment to laminin. PMA treatment re- 
sulted in attachment to laminin within 4-120 hours. 
The magnitude of the increase and the time course for 
its development differed amongst the cell lines. Jurkat  
and HPB-ALL showed increases at the earliest time- 
point (Tables 3 and 4) with maximal levels achieved 
within 48-72 hours. In contrast, the M o b 4  and CEM 
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Fig 3. Effects of rabbit polyclonal antibodies to fibronectin and lami- 
nin on Jurkat cell attachment to these matrix components. The sub- 
strates were prepared as described in Materials and Methods. Both 
substrates were then treated for 30 minutes a t  room temperature with 
a 1 : l O  dilution of antifibronectin serum, antilaminin serum, or normal 
rabbit serum. At the end of the incubation period, the sera were re- 
moved and the substrates washed in assay buffer. PMA-treated (48 
hrs) Jurkat cells were then added. The percentage of attached cells 
after 4 hours of incubation was measured as described in Materials 
and Methods. Data points represent means and standard deviations 
based on triplicate samples per data point in a single experiment. The 
experiment was repeated two times with similar results. 
lines did not show an increase until the 48-hour time 
point, with maximal levels achieved after 120 hours of 
incubation. The HSB-2 line displayed only a minimal 
increase after 5 days of continuous treatment. 
DISCUSSION 
In normal T-cells (Shimizu et  al., 1990~1, pl integrin- 
mediated binding to laminin and fibronectin increases 
rapidly in response to treatment with phorbol esters 
and mitogenic Mabs. This initial response does not re- 
quire new receptor synthesis, thus presumably reflects 
conversion of pre-existing receptors to a high avidity 
state. In addition, the density of multiple pl-integrins 
is significantly higher on memory than on naive cells 
presumably reflecting induction of new receptor syn- 
thesis during antigen driven differentiation (Shimizu 
et al., 1990~). Thus normal T-cells regulate both the 
avidity and the density of the p l  integrins in response 
to activation. Previous studies indicated that like nor- 
mal cells, the Jurkat line responds to PMA with rapid, 
density independent upregulation of pl-integrin func- 
tion (Chan et al., 1991). However, induction of new 
receptor synthesis has not been reported in cell lines. 
The current study describes a variant of the Jurkat cell 
line in which PMA treatment increases the avidity, 
synthesis and surface expression of several pl-inte- 
grins. 
As reported previously for Jurkat cells, this variant 
binds constitutively to fibronectin and, to a lesser de- 
gree, laminin (Chan et al., 1991). PMA treatment re- 
20 4 1 
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Effects of cvclohexamide on PMA-induced up-regulation of Fie. 4 
Jurkat cell adhesionto fibronectin or laminin. Untreated JGrkat cells, 
Jurkat cells treated with PMA a t  the time of assay, and Jurkat cells 
pre-treated with PMA for 48 hours in the presence or absence of cyclo- 
hexamide were examined for attachment to  fibronectin and laminin in 
the normal manner. Data points represent means and standard devia- 
tions based on triplicate samples in a single experiment. The differ- 
ence in adhesion to laminin after treatment with PMA alone and PMA 
combined with 5 x lo-' M cyclohexamide were statistically signifi- 
cant using the Student t-test ( P  i 0.05). The experiment was repeated 
four times with similar results. 
sults in biphasic up-regulation of attachment. Marked 
spreading and a 2-5-fold increase in attachment to both 
matrix components develops within hours. This phase 
is not associated with an increase in receptor expres- 
sion nor is it blocked by cyclohexamide; therefore, a 
change in receptor avidity is the most likely mecha- 
nism. Attachment to fibronectin peaks during this ini- 
tial phase. However, adhesion and spreading on lami- 
nin continues to rise peaking at 10-20-fold over 
baseline after 48-72 hours of incubation. A sixfold in- 
crease in expression of the a6 epitope accompanies this 
second phase. Interestingly, the density of the p l  
epitope does not increase significantly suggesting that 
changes in alpha chain synthesis determine expression 
of the heterodimer at the cell surface. Inhibition of pro- 
tein synthesis inhibits the late increases in both lami- 
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Fig. 5. Flow cytometric analysis of pl integrin expression on  Jurka t  
cells. Cells were treated for 24 hours with 5 X 10 7M cyclohexamide 
(cyclohex, 24 hrs), 5 nM PMA (PMA, 24 hrs), or both cyclohexamide 
and PMA (PMA, cyclohex, 24 hrs). After washing, untreated KJT) cells 
and the three treated populations were stained for a4 (a), a5 (bl, a6 
(c ) ,  and 61 (d) epitopes. Staining and flow cytometric analysis were 
carried out  as described in Materials and Methods. Graphs show cell 
TABLE 1. Up-regulation of p l  integrins on the surface of PMA-treated 
Jurkat cells’ 
Relative fluorescence intensity Monoclonal 
antibody Specificity 4 hours 24 hours 48 hours 
B1E5 u5 133 ? 20 171 f 18 241 ? 13 
J1B5 u6 9 3  ? 7 480 2 40 601 f 71 
‘Flow cytometric indirect immunofluorescence studies were conducted as described in  
Materials and Methods. The mcan fluorcsccncc intcnsitics for each marker (linear 
scale) were normalized to means obtained with untreated cells. Tliub a value uT 100 
indicatcs that  thrrr  has hcen no change in marker expression in the PMA-treated cells 
relative to unheated control cells. A value uf‘ 1.000 indicates a ten-fold increase. Data 
points represent means L ranges based on duplicate samples in single expenment. The 
experimcnt was rcpeated three times with similar results. 
nin binding activity and the density of the a6 epitope. 
Thus new receptor synthesis contributes to the increase 
in laminin binding activity a t  late time points. The fact 
that attachment increases to a greater degree than re- 
ceptor expression suggests the newly synthesized re- 
ceptors are in a “high avidity” state. Therefore, maxi- 
mal binding activity is a function of both receptor 
density and avidity in lymphoid cells. PMA augments 
adhesion through both mechanisms in Jurkat cells. 
f 
.....-... i 1 .  
number vs. fluorescent intensity on a 3-decade, 256 channel log scale 
(intensity doubles every 24 channels). The background staining with 
both pooled mouse IgG (control for a4 and cu5) and pooled ra t  IyG 
(control for a6 and 61) showed 90% of the cells in  the “negative” peak 
seen a t  the  extreme left in (b) and (c). The arrowhcads identify the 
“mean” channel and the numbers above give the percentage of pofiitive 
cells. 
TABLE 2. Inhibition of Jurkat cell attachment to fibronectin and 
laminin with antibodies to f31 integrins’ 
Percent attached Monoclonal 





P l  
a5 
a6 
55 * 3 
13 * 4 
52 2 6 
62 L 4 
1 * 2  l + l  
52 + 3 
13 ? 4 
’The at.tachment assays were carried out a b  described in Materials and Methods using 
Jurkat  cclls that  had been treated for 2 days with PMA. Prior to addition nf cclls to the 
substrate, the cells were incubated for 15 ininules with the various monoclonal antibud- 
ies 11:10 final dilution of hybridoma supernatants) and then transferred to the fibronec- 
tin- or laminin-coated wells. Data points represent means and standard deviations 
based on triplicate samples in a single experiment. The experiment wab: repealed three 
times with similar results. 
After 24-72 hours treatment with PMA, the u5 spe- 
cific Mab B1E5 blocks 76% of adhesion on fibronectin, 
whereas the a6 specific Mab GoH3 blocks 80% of the 
attachment on laminin. In contrast, a Mab directed at 
the common pl-chain, AIIBB, blocks 99% of the attach- 
ment on both substrates. Thus the pl-integrin family 
mediates both the early (Chan et al., 1991) and late 
increases in attachment to fibronectin and laminin fol- 
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TABLE 3. Effect of staurosporine on tho funct ion and expression 
of p,l-integrins' 
Binding activity Expression 
Treatment Laminin Fibronectin ( ~ 5  a6 
4 Hours 
1;ntreated 
50 mM Staur 
PMA 
PMA+BO mM Staur 
24 hours 
Untreated 
50 mM Staur 
PMA 
I'MhL5O mM Stauro 
769 1391 7,977 i32% I
423 (2%)  6,807 (275T 1 
3,184 113%) 12 481 (50%) 
186 (1%) 7,322 129%) 
534 ( 9 8 ,  7,359 (29%) 
300 (1%) 5,378 (22%) 
6,324 (25%) 12,898 (52% 1 









'Jurkat cells treated with PMA for a total of 4 or 24 hours (including the 4 hour periud of 
the adhesion assay.  Adhesion and marker expressiun were measured as described in 
Materials and Methods. Binding activ1t.v IS given as the mmn number I"r of :iddcdl of 
cells attached to the wells after washing (triplicate dc!termination). EpiLnpe expramon 
is given as the lmcan fluorrscence with a-chain speciric Mal, mean fluurescence with 
isotype controls1 tlinc.ar scales:. Similar findings were obtained in three independent 
experiments. 
TABLE 4. Attachment of different T-lymphwblastic cel l  l i nes  to 
fibronectin and laminin' 
Percent attached 
Substmte IJntreated ( 4  8 hours) (1-2 days) 13-5 days) 
Fibrnneet in  
PMA PMA PMA 
I7SR-2 27 2 6 55 2 4 48 ' 9 - 
CEM 18 + 6 56 2 5 49 i 17 - 
M o b 4  13 + 4 44 2 16 48 2 5 - 
IIPK-ALL 10 i 6 47 -c 6 46 + 6 - 
IISB-2 1 - 1  3 2 1  1 2 1  6 - 1  
(:EM 1 . 1  2 2 1  7 + 5  1 t i 2 4  
Molt-4 1 ' 2  2 - c l  3 +. 1 28 2 ti 
HPB-ALl, 1 2 1  7 1 1  18 ' 3 20 - 5 
'Attachment of varinus T-lymphohlastic lines to fibronectin and laminin under control 
conditions and after treatment with PMA. The attachment 
described in Materials and Methods Data points represent means and standard errors 
taken from a large number of Independent experiments. 
treaced with I'MA a t  the start of the adhesion assay; m other 
to 4 hours was perfiirnird. Data Crum these experiments have been cunibined under the 
heading: PMA. p8 liours The long-term pretreatmrnt groups includr data pooled from 
experimenm in which cells were treated for 1-2 days or :I-5 days. 
Laminin 
lowing PMA treatment. VLA-5 (or51fi1) and VLA-6 icu6i 
P l )  are the principle receptors for fibronectin and lami- 
nin, respectively, with lessor contributions from other 
members of the f3l family. 
The most likely targets for PMA in Jurkat  cells, par- 
ticularly at the low concentrations employed in the cur- 
rent study, are one or more isoforms of protein kinase C 
ipkC'l (Knopf et al., 1986; Beyers et al., 1988; Nishi- 
zuka, 1988; Ono et al., 1988). PKCs are the best-docu- 
mented receptors for phorbol esters in lymphoid cells 
(Tmboden and Weiss, 1988). SerineJthreonine kinases 
in the Erk (MAP kinasei family also respond to PMA in 
whole cells (Hoshi et al., 1988; Nel et al., 1991). How- 
ever, these responses are most likely the result of C-ki- 
nase initiated phosphorylation cascades (reviewed in 
(Crews et al., 1992)). Protein-tyrosine kinases may also 
be substrates for pkCs (Veillette et al., 1988); however, 
direct activation by phorbol esters has not been de- 
scribed. In T cells, for example, tyrosine phosphoryla- 
tion of the 6 chain of CD3 is not induced by either 
phorbol esters or diacylglycerol (Klausner and Samel- 
son, 1991). Recently, direct activation of phospholipase 
TI (PLD) in lymphocytes by phorbol esters has been 
postulated (Cao et  al., 1990). This conclusion rests pri- 
marily on the observation that several inhibitors of 
C-kinase activity fail to prevent upregulation of PLD 
by phorbol esters in intact cells. However, phorbol es- 
ters do not up-regulate PLD in membrane preparations 
as one would expect if direct binding and activation 
occurred. Thus C-type kinases remain the only en- 
zymes in which activation following binding of phorbol 
esters has been clearly documented for the purified en- 
zyme (Ono ct al., 1989). 
In lymphoid cells, activation and translocation of 
C-type kinases occur within minutes of initiating treat- 
ment with PMA iAse et al., 1988; Kim et al., 1989). 
However, continuous treatment depletes lymphoid 
cells of PKC activity within hours to days. Therefore, 
depletion as well as activation of C-kinases may con- 
tribute to the de novo synthesis of integrins following 
continuous treatment with PMA. The existence ofmul- 
tiple PKC isoforms in the Jurkat line further compli- 
cates interpretation since thrir relative sentivities t o  
PMA have not been established (Koretzky et al., 1989). 
These issues illustrate the complexity of the pathways 
involved in the response t o  PMA and highlight the need 
for further investigation. 
The blockade of PMR-induced matrix adhesion by 
staurosporine further illustrates the role of' protein ki- 
nases in regulating P l  integrin function. Jurkat  cells 
treated with PMA and staurosporine bound to the nia- 
trix molecules; however, the twofold (fibronectin) and 
five- to tenfold (laminin) increases in binding following 
PMA treatment alone were suppressed. Staurosporine 
blocked both the early and late responses to PMA. Inhi- 
bition of the early response did not result from loss of 
receptors a t  the cell surface since the expression ofthe 
or5 and or6 epitopes were unchanged. In contrast, inhibi- 
tion of the late increase in laminin binding activity 
reflects, in part, suppression of new receptor synthesis 
since staurosporine prevents the threefold rise in tr6 
expression after 20 hours with PMA. Thus increases in 
the activities of one or more protein kinases mediate 
both the initial increase in the avidity of fi1 integrins 
and the late increase in expression of functional a6lfil 
receptors a t  the cell surface. 
Finally, the responses of T-lymphoblastic cell lines to 
PMA indicate a link between developmental maturity 
and expression of functional receptors for fibronectin 
and laminin. Previous studies document phenotypic 
changes in T-lymphoblastic cell lines consistent with 
cellular difrerentiation and activation following treat- 
ment with PMA (Stoolman and Ebling, 1989). In the 
current study, binding to laminin developed rapidly 
(4-48 hours) in the most phenotypically mature cell 
lines (HPB-ALL and Jurkat). I ines  showing intermedi- 
ate levels of maturity, Molt-4 and CEM, required 
longer incubations with PMA (48-120 hours). The least 
mature line, HSH-2, required the longest incubation 
(120 hours) and showed the weakest response. Thus 
only T-lymphoblastic lines resembling thymocytes a t  or 
beyond stage I1 develop significant laminin binding ac- 
tivity in response to PMA. In contrast, all cell lines 
showed constitutive binding to fibronectin. We propose 
that in human T-lymphoblastic malignancies, as  in 
their normal counterparts (Wadsworth et al., 1992), the 
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expression of functional receptors for laminin is devel- 
opmentally regulated. 
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